Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
GUANGZHOU, China & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 12, 2026-- Vibrant Therapeutics (“Vibrant”), a clinical-stage biotechnology company developing next-generation intelligent therapeutics, today announced $61 million in new financing. The …